Search Results - "Datoo MS"

The R21/Matrix-M malaria vaccine: questions remain - Author's reply.

Authors: Datoo MS Hill AVS Beaumont E et al.

Source: Lancet (London, England) [Lancet] 2025 Jan 25; Vol. 405 (10475), pp. 299-301.

Publication Type: Letter

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE; In Process

A structure-based epitope tagging approach identifies vulnerable sites on the malarial P36-P52 protein complex for antibody-mediated neutralization of Plasmodium sporozoites.

Authors: Das, Samhita Boeykens, Lien Loubens, Manon et al.

Source: PLoS Pathogens. 7/8/2026, Vol. 22 Issue 7, p1-25. 25p.

Antibody fine specificity correlates with protection from malaria for the RTS,S vaccine in young African children: A post hoc analysis of a phase IIb randomised controlled trial.

Authors: Hysa, Alessia Opi, D. Herbert Waterhouse, Joshua et al.

Source: PLoS Medicine. 5/14/2026, Vol. 23 Issue 5, p1-22. 22p.

Combining seasonal malaria chemoprevention with novel therapeutics for malaria prevention: a mathematical modelling study.

Authors: Braunack-Mayer, Lydia Malinga, Josephine Nekkab, Narimane et al.

Source: PLoS Computational Biology. 2/26/2026, Vol. 22 Issue 2, p1-18. 18p.

Structural basis for conserved and distinct antigen recognition by a lineage of malaria-protective antibodies.

Authors: Jain, Monika Cannac, Fabien Agrawal, Sashank et al.

Source: PLoS Pathogens. 6/3/2026, Vol. 22 Issue 6, p1-26. 26p.

Health system readiness and barriers to effective deployment of the R21 malaria vaccine in Nigeria.

Authors: Shittu, Abdulqoyyum Olayinka Oshinowo, Medinat Adenike Offia, Hannah et al.

Source: Discover Public Health. 5/19/2026, Vol. 23 Issue 1, p1-10. 10p.

R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial.

Authors: Kibwana E Bundi C Kimani D et al.

Source: Frontiers in immunology [Front Immunol] 2025 Jul 07; Vol. 16, pp. 1620365. Date of Electronic Publication: 2025 Jul 07 (Print Publication: 2025).

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Systemic infection with insect-specific viruses does not affect Plasmodium sporozoite formation in Anopheles mosquitoes.

Authors: Schinkel, Michelle Overheul, Gijs J. Ploeger, Ellen et al.

Source: PLoS Neglected Tropical Diseases. 12/26/2025, Vol. 19 Issue 12, p1-15. 15p.

Implementation strategies for the introduction of the RTS,S/AS01 (RTS,S) malaria vaccine in countries with areas of highly seasonal transmission: workshop meeting report.

Authors: Merle, Corinne S. Badiane, Ndeye A. Affoukou, Cyriaque Dossou et al.

Source: Malaria Journal. 8/23/2023, Vol. 22 Issue 1, p1-14. 14p.

Heterogeneous impacts for malaria control from larviciding across villages and considerations for monitoring and evaluation.

Authors: Sherrard-Smith, Ellie Fillinger, Ulrike Tia, Jean-Philippe B. et al.

Source: PLoS Pathogens. 7/28/2025, Vol. 21 Issue 7, p1-27. 27p.

Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial.

Authors: Kapulu MC Orenge F Kimani D et al.

Source: Nature medicine [Nat Med] 2026 Jan; Vol. 32 (1), pp. 178-185. Date of Electronic Publication: 2026 Jan 06.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Malaria Prevention: Progress to Date.

Authors: Grobusch MP Schnyder JL Schlagenhauf P et al.

Source: Drugs [Drugs] 2026 Jul; Vol. 86 (7), pp. 971-988. Date of Electronic Publication: 2026 Apr 27.

Publication Type: Journal Article; Review

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1950 (Electronic) Linking ISSN: 00126667 NLM ISO Abbreviation: Drugs Subsets: MEDLINE

Awareness, acceptability, and willingness to pay for the R21/Matrix-M malaria vaccine: a cross-sectional study among pregnant women and nursing mothers in Enugu State, Nigeria.

Authors: Dim, Obinna Felix Chima, Uzochukwu Emmanuel Iloabuchi, Francis Chibuike et al.

Source: BMC Public Health. 11/18/2025, Vol. 25 Issue 1, p1-11. 11p.

Mathematical modeling of malaria vaccination with seasonality and immune feedback.

Authors: Qu, Zhuolin Patterson, Denis Zhao, Lihong et al.

Source: PLoS Computational Biology. 5/12/2025, Vol. 21 Issue 5, p1-32. 32p.

Mitigation of Malaria in Sub-Saharan Africa through Vaccination: A Budding Road Map for Global Malaria Eradication.

Authors: Alum, Esther Ugo Ainebyoona, Christine Egwu, Chinedu Ogbonnia et al.

Source: Ethiopian Journal of Health Sciences. May2025, Vol. 35 Issue 3, p205-217. 13p.

Malaria vaccines in India: Bridging the gap between hope and reality.

Authors: Samajdar, Shambo Samrat Chatterjee, Rupak Mukherjee, Shatavisa et al.

Source: One Health Bulletin. Dec2025, Vol. 5 Issue 4, p147-148. 2p.

A perspective on Oxford's R21/Matrix-M™ malaria vaccine and the future of global eradication efforts.

Authors: Aderinto, Nicholas Olatunji, Gbolahan Kokori, Emmanuel et al.

Source: Malaria Journal. 1/12/2024, Vol. 23 Issue 1, p1-4. 4p.

Genetic diversity and natural selection of circumsporozoite surface protein in Vietnam Plasmodium falciparum isolates.

Authors: Võ, Tuấn Cường Lê, Hương Giang Kang, Jung-Mi et al.

Source: Malaria Journal. 10/8/2025, Vol. 24 Issue 1, p1-14. 14p.

Seasonal mass vaccination with R21/Matrix-M for malaria elimination (SERVAL): protocol of the cluster randomised trial.

Authors: Dabira, Edgard D. Natama, H. Magloire Jaiteh, Fatou et al.

Source: Trials. 9/29/2025, Vol. 26 Issue 1, p1-12. 12p.

Genetic polymorphism of circumsporozoite protein of Plasmodium falciparum isolates in children in Brazzaville, Republic of Congo.

Authors: Baina, Marcel Tapsou Djontu, Jean Claude Ntabi, Jacque Dollon Mbama et al.

Source: Malaria Journal. 8/29/2025, Vol. 24 Issue 1, p1-12. 12p.